Abnormal FGFR 3 Expression in Cartilage of Thanatophoric Dysplasia Fetuses

By Delezoide Anne-Lise   Lasselin-Benoist Catherine   Legeai-Mallet Laurence   Brice Peggy   Senée Valérie   Yayon Avner   Munnich Arnold   Vekemans Michel   Bonaventure Jacky  

Human Molecular Genetics, Vol. 6, Iss. 11, 1997-10 ,pp. : 1899-1906

Oxford University Press

Access to resources Recommend Favorite

A novel FGFR3-binding peptide inhibits FGFR3 signaling and reverses the lethal phenotype of mice mimicking human thanatophoric dysplasia

By Jin Min   Yu Ying   Qi Huabing   Xie Yangli   Su Nan   Wang Xiaofeng   Tan Qiaoyan   Luo Fengtao   Zhu Ying   Wang Quan   Du Xiaolan   Xian Cory J.   Liu Peng   Huang Haiyang   Shen Yue   Deng Chu-Xia   Chen Di   Chen Lin  

Human Molecular Genetics, Vol. 21, Iss. 26, 2012-12 ,pp. : 5443-5455

Oxford University Press

Access to resources Recommend Favorite

Structural and functional characterization of the mouse Sox9 promoter: implications for campomelic dysplasia

By Kanai Y.   Koopman P.  

Human Molecular Genetics, Vol. 8, Iss. 4, 1999-04 ,pp. : 691-696

Oxford University Press

Access to resources Recommend Favorite

Sustained ERK1/2 but not STAT1 or 3 activation is required for thanatophoric dysplasia phenotypes in PC12 cells

By Nowroozi Nakisa  

Human Molecular Genetics, Vol. 14, Iss. 11, 2005-06 ,pp. : 1529-1538

Oxford University Press

Access to resources Recommend Favorite

Loss of DNA-dependent dimerization of the transcription factor SOX9 as a cause for campomelic dysplasia

By Sock E.  

Human Molecular Genetics, Vol. 12, Iss. 12, 2003-06 ,pp. : 1439-1447

Oxford University Press

Access to resources Recommend Favorite